Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
Breast-Conserving Surgery More Likely At Breast Centers
http://www.medicalnewstoday.com/articles/121468.php
Breast cancer patients are twice as likely to be offered breast-conserving surgery if treated by surgeons at breast centers than by surgeons in private practice, according to a national survey of breast specialists conducted by the American Society of Breast Disease.
Surveillance Mammography After Treatment For Primary Breast Cancer
http://www.medicalnewstoday.com/articles/121465.php
The National Institute for Health Research Health Technology Assessment (NIHR HTA) programme has commissioned a new study to identify the most effective and efficient surveillance methods for women who have received treatment for primary breast cancer.
Appropriate Lifestyle Choices Can Reduce The Risk Of Breast Cancer - Europa Donna
http://www.medicalnewstoday.com/articles/121464.php
Breast cancer claims the lives of more European women than any other cancer. Almost 132,000 women died from breast cancer in 2006, and every year 430,000 European women are diagnosed with the disease.
HER2 Breast Cancer Vaccine Shows Promise In Lab
http://www.medicalnewstoday.com/articles/121459.php
Researchers in the US are hoping that their new breast cancer vaccine will be effective in humans because it safely destroyed HER2-positive tumors, even those resistant to anti-HER2 drugs, when tested on mice.
Vaccine Against HER2-Positive Breast Cancer Offers Complete Protection In Lab
http://www.medicalnewstoday.com/articles/120786.php
Researchers at Wayne State University have tested a breast cancer vaccine they say completely eliminated HER2-positive tumors in mice - even cancers resistant to current anti-HER2 therapy - without any toxicity.
----------------------------------------------
** CANCER / ONCOLOGY News **
Emerging Therapies, Including Bristol-Myers Squibb/Medarex's Ipilimumab, Will Drive Growth In The Malignant Melanoma Drug Market
http://www.medicalnewstoday.com/articles/121476.php
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the malignant melanoma drug market, driven by the launch of emerging agents, will experience robust annual 12 percent growth through 2012 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
Promising Clinical Phase I Results For Intravenous CP-4126 For Patients With Solid Tumours
http://www.medicalnewstoday.com/articles/121471.php
Clavis Pharma ASA (OSE: CLAVIS) announced that promising results from its Intravenous CP-4126 Phase I study in patients with solid tumours have been presented at the European Society for Medical Oncology (ESMO) Meeting 2008.
Breast-Conserving Surgery More Likely At Breast Centers
http://www.medicalnewstoday.com/articles/121468.php
Breast cancer patients are twice as likely to be offered breast-conserving surgery if treated by surgeons at breast centers than by surgeons in private practice, according to a national survey of breast specialists conducted by the American Society of Breast Disease.
Merck KGaA: Erbitux - First Treatment In 30 Years To Prolong Survival In 1st-Line Recurrent And/Or Metastatic Head And Neck Cancer
http://www.medicalnewstoday.com/articles/121467.php
Data presented at the 33rd European Society for Medical Oncology (ESMO) Congress in Stockholm demonstrate that the addition of Erbitux® (cetuximab) to platinum-based chemotherapy increases overall survival (OS) compared to chemotherapy alone in the 1st-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN).
Appropriate Lifestyle Choices Can Reduce The Risk Of Breast Cancer - Europa Donna
http://www.medicalnewstoday.com/articles/121464.php
Breast cancer claims the lives of more European women than any other cancer. Almost 132,000 women died from breast cancer in 2006, and every year 430,000 European women are diagnosed with the disease.
Renal Cell Carcinoma Rates Compared With Health Status And Behavior In The United States
http://www.medicalnewstoday.com/articles/121451.php
UroToday.com - Renal cell cancer is the third most common urologic malignancy and the seventh most common cancer overall. Incidence rates have been increasing steadily each year in the United States (U.
Prognostic Factors In Invasive Squamous Cell Carcinoma Of The Penis: Analysis Of 196 Patients Treated At The Brazilian National Cancer Institute
http://www.medicalnewstoday.com/articles/121448.php
UroToday.com - Cancers of the penis are uncommon tumors in the Brazilian male population, but they are a significant health problem in some regions of the country. The superficial location of these tumors provides the opportunity for early detection and conservative treatment.
California Researcher And Surgeon, Donald L. Morton, MD, To Receive ACCC's Clinical Research Award
http://www.medicalnewstoday.com/articles/121439.php
Donald L. Morton, MD, will receive the Association of Community Cancer Centers' 2008 Clinical Research Award. He will be honored for his extensive research, leadership, and commitment to individuals with melanoma.
Endoscopic Ultrasound Guided Anti-Tumor Therapy May Allow Doctors To Fight Cancer More Safely And Effectively
http://www.medicalnewstoday.com/articles/121421.php
The chairman of EUS2008 has announced that investigational research on a therapeutic technique that will allow physicians to directly inject malignant tumors with cancer fighting agents from inside the body was presented at the 16th International Symposium of Endoscopic Ultrasonography (EUS2008) in San Francisco on September 12-13.
SUTENT(R) Cost Effective Advantage Predicted In Treating Patients With Metastatic Renal Cell Carcinoma
http://www.medicalnewstoday.com/articles/121309.php
Results from an international study presented today at the European Society for Medical Oncology (ESMO) predict that sunitinib (SUTENT®) is cost effective as a first-line therapy for patients with metastatic renal cell carcinoma (mRCC).
New Tool To Speed Cancer Therapy Approval Available
http://www.medicalnewstoday.com/articles/121103.php
Although cancer remains a leading cause of death in America, it can take up to 12 years to bring a new anti-cancer agent before the FDA and the success rate for approval is only five to 10 percent.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
Gardasil's FDA Approval Now Includes Some Vaginal And Vulvar Cancers
http://www.medicalnewstoday.com/articles/121491.php
The US Food and Drug Administration (FDA) has approved Merck's cervical vaccine Gardasil for protecting against vaginal and vulvar cancers caused by Human Papillomavirus (HPV) types 16 and 18 in girls and women aged from 9 to 26.
Cross-Protective Efficacy And Prevention Of Precancerous Vaginal Lesions Added To Gardasil(R) I Product Information
http://www.medicalnewstoday.com/articles/121461.php
The product information of the four-type (6,11,16,18) human papillomavirus (HPV) vaccine Gardasil® has been updated to include cross-protective efficacy in preventing precancerous cervical lesions (CIN2/3 and AISiii) due to additional cancercausing HPV types related to HPV type 16.
----------------------------------------------
** COLORECTAL CANCER News **
Avastin(R)(bevacizumab) Continues To Demonstrate Long Term Survival For Patients With Metastatic Colorectal Cancer
http://www.medicalnewstoday.com/articles/121460.php
Avastin's (bevacizumab) role in the treatment of patients with metastatic colorectal cancer (mCRC), the world's second most common cancer, was strengthened at the 33rd European Society of Medical Oncology (ESMO) meeting with a compelling data set including: - the final overall survival analysis of a 2,000 patient community-based study - further analyses of the bevacizumab and cetuximab combination study highlighting K-Ras Findings - strong and consistent outcome for elderly patients on bevacizumab -based therapy <b>Long-term overall survival reported from First BEAT 1</b>The long term benefits of bevacizumab use in combination with chemotherapy were confirmed in the 1,965 patient First BEAT study, which combined bevacizumab with commonly used chemotherapies in mCRC.
Identification Of Cancer-Causing Gene In Many Colon Cancers
http://www.medicalnewstoday.com/articles/121425.php
Demonstrating that despite the large number of cancer-causing genes already identified, many more remain to be found, scientists at Dana-Farber Cancer Institute have linked a previously unsuspected gene, CDK8, to colon cancer.
----------------------------------------------
** LUNG CANCER News **
No news for this category today.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
Cyclacel Expands Phase 2 Sapacitabine Trial In Elderly AML To Include Patients With MDS
http://www.medicalnewstoday.com/articles/121446.php
Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) (NASDAQ:CYCCP) announced that it has advanced sapacitabine into Phase 2 development as a second-line treatment for myelodysplastic syndromes (MDS).
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
Serum Androgen Normalization Kinetics & Factors Linked To Testosterone Reserve After Limited Androgen Deprivation Therapy
http://www.medicalnewstoday.com/articles/121456.php
UroToday.com - How rapidly serum androgen levels fall after androgen-deprivation therapy (ADT) and recover between cycles for patients with prostate cancer (CaP) undergoing intermittent androgen suppression (IAS) is not well studied.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment